Clinical Trials Sponsored by Huda Salman

Total 1222 results

Huda Salman

Recruiting

Chimeric Antigen Receptor T Cell Redirected to Target CD4 Positive Relapsed Refractory Acute Myeloid Leukemia (AML ) as a Bridge to Allogeneic Stem Cell Transplant

Acute Myeloid Leukemia

United States
Huda Salman
iCell Gene Therapeutics

Recruiting

CD4CAR for CD4+ Leukemia and Lymphoma

T-cell Lymphoma | T-cell Leukemia

United States
Huda Salman
The Leukemia and Lymphoma Society; iCell Gene Therapeutics

Recruiting

Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML.

Chronic Myelomonocytic Leukemia

United States
Huda Fahmy Mahmoud, PhD

Completed

High Flow Nasal Oxygenation Versus Non-invasive Ventilation for Patients With Blunt Chest Trauma

Chest Trauma

Egypt
Huda Fahmy Mahmoud, PhD

Completed

Ketamine Versus Dexmedetomidine for Prevention of Postoperative Delirium

Emergence Delirium

Egypt
Huda Fahmy Mahmoud, PhD

Completed

Lidocaine Versus Bupivacaine for Sphenopalatine Ganglion Block

Septum; Deviation, Congenital

Egypt
Cuda Anesthetics, LLC

Completed

Pilot Study of Bioequivalence of Cudafol(R) and Diprivan(R) Administered as Single Intravenous Doses in Healthy Subjects

Healthy Subjects
Esraa Salman Jasim
University of Baghdad

Recruiting

Effectiveness of PEEK Fixed Retainer (RCT)

Retention

Iraq
Dr Salma kafeel Qureshi

Recruiting

Role of Immunoglobulin in Male Infertility

Male Subfertility

Pakistan
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Gallbladder Neoplasms (IRE)

Gallbladder Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Rectal Neoplasms

Rectal Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Esophageal Neoplasms (IRE)

Esophageal Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Percutaneous Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome

Liver Cancer

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Renal Pelvic and Ureteral Neoplasms (IRE)

Renal Pelvic and Ureteral Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Combination of PD-1 and VEGFR-2 Blockade for Advanced Hepatocellular Carcinoma

Progress Free Survival (PFS) and Overall Survival (OS)

China
Fuda Cancer Hospital, Guangzhou

Completed

Phase II/III of Randomized Controlled Clinical Research on IRE Synchronous Chemotherapy for LAPC

Locally Advanced Pancreatic Adenocarcinoma

China
Fuda Cancer Hospital, Guangzhou

Withdrawn

Chimeric Antigen Receptor-Modified T Cells for Breast Cancer

Breast Cancer

China
Fuda Cancer Hospital, Guangzhou

Withdrawn

CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients

GD2 Positive Glioma | CAR-T Cell Immunotherapy

China
Fuda Cancer Hospital, Guangzhou

Withdrawn

CD19-targeting CAR T Cells for B Cell Lymphoma

B Cell Lymphoma

China
Fuda Cancer Hospital, Guangzhou

Withdrawn

HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Cancer

Pancreatic Cancer

China
Fuda Cancer Hospital, Guangzhou

Completed

Safety and Efficacy Study of Mix Vaccine in Pancreatic Carcinoma Patient

Pancreatic Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Cervical Carcinoma

Cervical Carcinoma

China
Fuda Cancer Hospital, Guangzhou

Completed

Liver Cancer HepaSphere Combined With Cryosurgery

Liver Cancer

China
Fuda Cancer Hospital, Guangzhou

Completed

HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Fuda Cancer Hospital, Guangzhou

Completed

HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Cancer

Liver Cancer

China
Fuda Cancer Hospital, Guangzhou

Completed

The Detection of Circulating Tumor Cells (CTCs) in Patients With Lung Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment

Neoplastic Cells, Circulating

China
Fuda Cancer Hospital, Guangzhou

Completed

The Detection of Circulating Tumor Cells (CTCs) in Patients With Liver Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment

Neoplastic Cells, Circulating

China
Fuda Cancer Hospital, Guangzhou

Completed

The Detection of Circulating Tumor Cells (CTCs) in Patients With Prostatic Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment

Neoplastic Cells, Circulating

China
Fuda Cancer Hospital, Guangzhou

Completed

The Detection of Circulating Tumor Cells (CTCs) in Patients With Breast Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment

Neoplastic Cells, Circulating

China
Fuda Cancer Hospital, Guangzhou

Completed

The Detection of CTCs in Patients With Pancreatic Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment.

Neoplastic Cells, Circulating

China
Salvat

Completed

SVT-15652 Otic Solution for the Treatment of Otomycosis

Otomycosis

United States
Salvat

Completed

Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-1) (CLOSE-1)

Cataract

United States
Salvat

Completed

SVT-15652 Otic Solution for the Treatment of Otomycosis.

Otomycosis

Spain
Salvat

Completed

Efficacy and Safety of DF289 Plus DF277 Otic Solution in the Treatment of Middle Ear Infections in Pediatric Patients

Acute Otitis Media

Spain
Salvat

Completed

Clinical Study to Assess the Efficacy and Safety of DF277 Compared to Placebo in the Treatment of Otic Eczema

Otic Eczema

Spain
Salvat

Completed

Clinical Study to Assess the Efficacy and Safety of G238 Compared to Clotrimazole Otic Solution in the Treatment of Otomycosis

Otomycosis

Spain
Salvat

Completed

SVT-40776 in Patients Suffering From Overactive Bladder Syndrome

Overactive Bladder (OAB)
Fuda Cancer Hospital, Guangzhou

No longer available

Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Carcinoma

Pancreatic Cancer

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Head and Neck Neoplasms (IRE)

Head and Neck Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Portal Venous Tumor Emboli (IRE)

Liver Cancer

China
Fuda Cancer Hospital, Guangzhou

Completed

Percutaneous Irreversible Electroporation for Unresectable Hepatic Carcinoma in Poor Liver Function

Hepatic Carcinoma

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Lymph Node Metastases(Close to Nerve) (IRE)

Lymph Node Metastases

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Urinary Bladder Neoplasms (IRE)

Urinary Bladder Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Laryngeal Neoplasms (IRE)

Laryngeal Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Extremities Neoplasms (IRE)

Extremities Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Stomach Neoplasms (IRE)

Stomach Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Simultaneous Gemcitabine and Irreversible Electroporation for Locally Advanced Pancreatic Cancer

Pancreatic Cancer

China
Fuda Cancer Hospital, Guangzhou

Withdrawn

CAR-T Cell Immunotherapy for EphA2 Positive Malignant Glioma Patients

CAR-T Cell Immunotherapy | EphA2 Positive Malignant Glioma

China
Fuda Cancer Hospital, Guangzhou

Withdrawn

CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients

CAR-T Cell Immunotherapy | Glioma of Brain
Fuda Cancer Hospital, Guangzhou

Completed

PENS or TENS for Pain in Liver Cancer

Pain | Liver Neoplasms | Cancer Pain

China

3

Subscribe